Pay in 4 interest-free payments of $6.70 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
10.1016/S0140-6736(12)60691-6 25
With some patients lacking health plan approval to get a break on the branded pharmaceutical products, the Hims & Hers plan might be attractive to patients to access lower-cost versions of these popular prescription medicines
Concerns with Unapproved GLP-1 Drugs Used for Weight Loss
But this strategy could subject Hims to risk of enforcement by the FDA and legal action from Novo, which has already filed over 60 lawsuits against firms unlawfully marketing semaglutide products and vowed to keep pursuing legal action against other entities engaged in similar conduct. When asked about its customized compounding approach, Hims directed Hunterbrook to information on its website about personalized healthcare, including an October white paper on the topic and a blog post highlighting their customers results with personalized weight loss products, as well as the Hims shareholder letter from Q3 2024
At present, microneedle patches remain experimental
